ALK5 inhibitor (Gubra/Ferring Pharmaceuticals)

N/A

Report date: 2025/06/11 10:32:12
NME

Base Information

Drug NameALK5 inhibitor (Gubra/Ferring Pharmaceuticals)
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionTransforming growth factor beta receptor 1 inhibitors
TargetsTransforming growth factor beta receptor 1
Therapy Area/IndicationsInflammatory Bowel Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryDenmarkSwitzerland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGubra Aps
China Registration ClassN/A

Develop Information

Active CompaniesGubra ApsFerring Pharmaceuticals A/S
Inactive CompaniesN/A
Active IndicationsInflammatory Bowel Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A